Asthma is a condition of narrow airways — and treatment is a matter of knowing which inhaler does what.

Asthma is a chronic inflammatory disease of the airways. Three things happen at once during an asthma episode: the muscles around the bronchial tubes tighten, the airway lining swells, and mucus production increases. The result is a narrowed passage for air — especially on exhale, which is why breathing out is harder than breathing in.

The inflammation is present even between attacks. This is the part that patients miss most often: asthma is not a problem that exists only when symptoms are bad. The underlying inflammation persists quietly, and if it is not treated, the airways become progressively more reactive. That is why controller medications are taken every day, including days when breathing feels normal.

Asthma is not the same as COPD, though both involve narrowed airways. Asthma typically begins in childhood or young adulthood, is reversible with treatment, and is driven by allergic and immune mechanisms. COPD usually begins later, is progressive, and is most often caused by long-term smoking. The two can overlap in some patients.

For patients who struggle with coordination — and this includes most children and many adults — a valved holding chamber (a "spacer") makes a meaningful difference. It captures the medication in a small chamber between the canister and the mouth, so the patient can breathe it in slowly without needing to time the press perfectly.

For controller inhalers that come as dry powder devices (no propellant, activated by the breath itself), the technique is different: no shaking, no spacer, and a fast forceful inhale. Using a metered-dose technique on a dry-powder inhaler — or vice versa — is a common error that leads to undertreatment.

Whatever the device, ask a pharmacist to watch you use it once. That single minute catches more errors than any instruction sheet.

In the United States, asthma medication pricing is more complicated than most classes. Albuterol — the standard rescue medication — is available as a low-cost generic and has been for years. Controller inhalers, however, have historically carried brand-only pricing, and until recently the newer devices cost several hundred dollars per month without insurance. Generic ICS and ICS/LABA combinations have started to enter the market, but availability varies by specific molecule and device.

What has changed is the comparison landscape. Regardless of which inhaler is prescribed, patients can compare prices across licensed U.S. pharmacies before filling — a live prescription price comparison takes about two minutes and the same logic applies across the entire respiratory category. When a generic equivalent exists, the price gap is often the largest single saving available on that prescription.

If you are starting an online refill for the first time, the process is documented step by step in this how to order prescriptions online guide — prescription first, licensed seller second, small first order third. If you want a plain-language reference on how generics differ from brand-name drugs, this generic drug guide covers the FDA standard that makes the price difference rational rather than suspicious.

Before you sign for a seller, verify them. A working VIPPS seal that resolves to a live NABP record, a real U.S. street address, and a prescription requirement that cannot be waived. Pages like this one about Metformin4You are a reasonable example of the transparency to expect — who runs the site, how sellers are selected, what criteria apply.

One practical note that matters more in asthma than in most conditions: do not skip controller doses because of cost. If the inhaler is not affordable, tell the prescriber. There is almost always a cheaper alternative — a generic ICS, a different device, a lower-priced equivalent — and skipping the daily controller is what leads to emergency department visits that cost far more than the prescription.